Theresa Devins

Theresa Devins has a diverse work experience in the pharmaceutical industry. Theresa started their career at TransCelerate BioPharma Inc. in 2014, where they worked on the diversification team. In 2005, they joined Boehringer Ingelheim and held various roles, including Senior Associate Director Clinical Operations and Senior Associate Director, Study Conduct, Oncology. From 2019 to 2020, they worked at Regeneron, where they were involved in Global Trial Operations and Global Trial Optimization. Theresa then joined Eisai US in 2020 as the Director, Neurology Business Group, Clinical Operations, and worked there until 2022. Currently, they serve as the Head of Clinical Operations at Cognition Therapeutics, Inc., starting in 2023.

Theresa Devins completed their Bachelor's Degree in Psychology at Purchase College, SUNY in 1997. Theresa then pursued further education at New York Medical College, where they obtained a Master's Degree in Clinical Research Administration. Theresa continued their studies at the same institution and completed their Doctor of Public Health (DrPH) degree between 1997 and 2003.